BWAY
Brainsway
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 3
Sell signal 1
Consensus Rating "Strong Buy"
Significant Net Income Growth
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BWAY
Brainsway Ltd.
A global leader in the advanced noninvasive treatment of brain disorders
Healthcare Equipment and Supplies
11/07/2006
04/17/2019
NASDAQ Stock Exchange
120
12-31
Depository Receipts (Ordinary Shares)
16 Hartum Street, RAD Tower, 14th Floor, Har HaHotzvim, Jerusalem, 9777516, Israel
Focus on the development and sale of non-invasive neuromodulation products.
Brainsway Ltd., was incorporated under the laws of the State of Israel on November 7, 2006. The company is a global leader in advanced non-invasive neurostimulation for the treatment of mental health disorders. The company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. The company is committed to leading through superior science and building on what is considered to be unparalleled clinical evidence. The company is the first and only TMS company to receive U.S. Food and Drug Administration (FDA) approval for three separate mental health disorder indications based on clinically proven efficacy, as demonstrated in a pivotal randomized placebo-controlled study. Current indications include major depression (MDD) (including the reduction of comorbid anxiety symptoms, commonly referred to as anxiety depression), obsessive-compulsive disorder (OCD), and smoking addiction.
Earnings Call
Q1/2025
Estimate EPS0.02
Actual EPS0.02
Estimate Revenue11.45M
Actual Revenue11.54M
BrainsWay's Q1 2025: Navigating Key Contradictions in Margins, Market Expansion, and Geopolitical Risks
May 20,2025 02:02
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BWAY has released its 2025 Q1 earnings. EPS was reported at 0.02, versus the expected 0.02, meeting expectations. The chart below visualizes how BWAY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BWAY has released its 2025 Q1 earnings report, with revenue of 11.54M, reflecting a YoY change of 26.84%, and net profit of 1.11M, showing a YoY change of 897.30%. The Sankey diagram below clearly presents BWAY's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
